The interesting thing that concerns me is that, at least for Medicare, they are adding coverage for GLP-1s to cover for an obesity diagnosis, and the program calls for Intensive Behavioral Therapy but the program indicates that a physician or NP or PA would need to deliver the IBT All this talk about spending millions of dollars educating physicians on nutrition when we all know they dont have time to counsel patients in-office due to the healthcare provider shortage
Not every vendor provides all of these, but the more data points present, the more confidence you can place in the product
While awaiting formal trials, some individuals report using BPC-157 "off-label" for: These anecdotes can offer hypotheses but must be treated cautiously due to: Until robust human data are available, consider the following safety points: Always prioritize products tested by third-party labs and stored under proper conditions
Care 21 , 16 (2021)
Each individual ingredient has its own research backing for healing, inflammation, and skin health, but the combination itself hasn't been formally tested as a single product
Amphetamine Hydrochloride